The health ministry is considering implementing a new system for drug exports in light of reports that subpar Indian medications have resulted in health issues and even fatalities in nations like US, The Gambia, and Uzbekistan, a report by NDTV said.
All drug samples made in India will undergo quality checks prior to shipping, the report added. According to ministry sources, this new policy is being discussed by the Union health ministry and the Department of Pharmaceuticals. Suggestions were also sought from the Directorate General of Foreign Trade (DGFT) regarding this.
Drug producers have up until now exported their products without any quality control directly to foreign nations after obtaining export permits.
Last month, the US government's top medical watchdog expressed concern about the spread of a highly drug-resistant bacteria linked to eye drops manufactured by an Indian company.
According to The New York Times, eye drops made by Chennai-based Global Pharma Healthcare under the brand name EzriCare Artificial Tears were linked to three deaths, eight cases of blindness, and dozens of infections. Tamil Nadu's drug regulator, on the other hand, stated that there was "no contamination" in the samples.
In October 2022, The Gambia in West Africa also reported the deaths of 70 kids allegedly linked to cough syrups made in India.
Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI
WHO stands by action of issuing alert against Maiden Pharma cough syrup
After Gambia, now Uzbekistan alleges Indian cold drug killed its children
Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit
Regulators halt eye products' production at Global Pharma Healthcare site
NITI Aayog to use private investment route to set up nuclear reactors
Himachal to invest 50% equity in ethanol project at Una: CM Sukhu
India to contribute 16% of global GDP over 2023-24: Morgan Stanley
Manufacturing, rise in air travel to take India oil demand to 5.4 mb/d
Import of PCs, medical devices, solar cells from China falls in FY23: GTRI
The children's deaths were strongly linked to the consumption of allegedly contaminated cough syrups made in India, a joint investigation conducted by the US Centres for Disease Control and Prevention (CDC) and the Gambian health authorities in March this year said.
In December, Uzbekistan claimed that at least 18 children in the country died after allegedly taking an India-manufactured cough syrup.